| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $494K | — | +31.7% |
| R&D Expense | $4.9M | — | -41.8% |
| SG&A Expense | $6.5M | — | -30.0% |
| Operating Income | -$10.9M | — | +37.0% |
| Net Income | -$3.1M | — | +84.1% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.8M | -41.3% | -35.7% |
| Current Assets | $6.2M | +12.4% | +32.4% |
| Total Assets | $80.1M | -1.5% | +191.0% |
| Current Liabilities | $83.0M | -9.5% | -0.1% |
| Long-term Debt | $59.4M | -1.0% | -7.4% |
| Total Liabilities | $118.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.5M | — | -32.8% |
| Capital Expenditures | $129K | — | +38.7% |
| Investing Cash Flow | -$129K | — | -38.7% |
| Financing Cash Flow | $9.2M | — | -21.5% |
| Free Cash Flow | -$12.6M | — | -32.9% |
| +5.1% |
| Stockholders' Equity | -$50.5M | +16.2% | +49.2% |